The Company is providing the following update on its wholly-owned subsidiary Pharm 2 Farm Limited (“P2F”).
As noted in the Company’s announcement of 11 November 2020, the Directors have been expecting the delivery and installation of its new anti-viral mask production line at or around the end of November.
Yesterday, 25 November 2020, the Company received an update from P2F and the manufacturer of the production line noting that the production machinery is now expected to undergo final acceptance testing in mid-December at the manufacturer’s premises in Spain.
It will then be shipped, installed and commissioned at P2F’s Biocity premises in Nottingham. Commercial production and shipment of product is now expected to begin in January 2021.
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned